Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Bacterial Cell Wall01:22

Bacterial Cell Wall

The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...
Special Staining Techniques01:13

Special Staining Techniques

Specialized staining techniques play a vital role in microbiology by enabling the visualization of specific bacterial structures that remain undetectable with standard microscopy methods. These techniques not only enhance the structural visualization of bacterial cells but also provide critical insights into their pathogenicity and classification. Additionally, they support diagnostic and research endeavors in microbiology by identifying key bacterial features.Capsule Staining for Virulence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activity of isavuconazole and comparator agents against pediatric isolates from invasive fungal infections.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Reduced Activity of Triazole Antifungal Agents Against Aspergillus tubingensis From a Global Collection of Genomically-Characterized Aspergillus Section Nigri Clinical Isolates (2020-2023).

Mycoses·2026
Same author

Multidrug-resistant Enterobacterales in United States hospitals: Frequency and susceptibility to newer β-lactamase inhibitor combinations (2020-2024).

International journal of antimicrobial agents·2026
Same author

Determination of frequency of spontaneous resistance for gepotidacin and levofloxacin against a collection of gram-positive and gram-negative organisms.

Antimicrobial agents and chemotherapy·2026
Same author

Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i> from Elderly Patients in Intensive Care Units of United States Medical Centers (2021-2025).

Antibiotics (Basel, Switzerland)·2026
Same author

In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against <i>Streptococcus pneumoniae</i> Responsible for Lower Respiratory Tract Infections in the United States (2016-2020), Including Resistant Subsets and Select Serotypes.

Antibiotics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 16, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

CEM-101 activity against Gram-positive organisms.

Leah N Woosley1, Mariana Castanheira, Ronald N Jones

  • 1JMI Laboratories, North Liberty, IA 52317, USA.

Antimicrobial Agents and Chemotherapy
|February 24, 2010
PubMed
Summary

CEM-101, a novel fluoroketolide, demonstrates potent in vitro activity against Gram-positive bacteria, showing greater bactericidal effects and lower resistance development than comparators. This new antimicrobial agent warrants further clinical evaluation for its promising characteristics.

More Related Videos

Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials
10:50

Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials

Published on: April 10, 2016

Detection of Bacteria Using Fluorogenic DNAzymes
13:20

Detection of Bacteria Using Fluorogenic DNAzymes

Published on: May 28, 2012

Related Experiment Videos

Last Updated: Jun 16, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials
10:50

Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials

Published on: April 10, 2016

Detection of Bacteria Using Fluorogenic DNAzymes
13:20

Detection of Bacteria Using Fluorogenic DNAzymes

Published on: May 28, 2012

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Macrolide resistance is a growing concern in treating Gram-positive bacterial infections.
  • Novel antimicrobial agents are needed to overcome existing resistance mechanisms.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of CEM-101, a new fluoroketolide.
  • To compare CEM-101's efficacy and resistance profile against established agents like telithromycin, macrolides, and lincosamides.

Main Methods:

  • Minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) were determined.
  • Timed killing assays, mutation rate studies, and postantibiotic effect (PAE) were performed.
  • Drug interaction synergy analyses were conducted.

Main Results:

  • CEM-101 exhibited potent bactericidal activity against Gram-positive organisms, with lower MBCs and greater potency than telithromycin.
  • Low propensity for resistance development was observed in single-step and multi-step mutation studies.
  • CEM-101 demonstrated significant concentration-dependent postantibiotic effects and synergistic activity with certain antibiotics.

Conclusions:

  • CEM-101 displays favorable in vitro antimicrobial characteristics, including potent activity and a low resistance potential.
  • Its efficacy and safety profile suggest CEM-101 is a promising candidate for further clinical investigation.
  • CEM-101 represents a valuable addition to the therapeutic options against challenging Gram-positive bacterial infections.